Breast Augmentation with Implants Medical Services in China

Breast augmentation, commonly referred to as augmentation mammoplasty, is a cosmetic surgical procedure designed to enhance breast size, shape, and symmetry using silicone or saline implants—or, less commonly, autologous fat transfer. It is not a treatment for disease per se but addresses aesthetic concerns, congenital hypoplasia, post-mastectomy reconstruction, or asymmetry following weight loss or pregnancy. Candidates undergo thorough preoperative evaluation—including physical examination, imaging (e.g., ultrasound or MRI), and psychological screening—to ensure realistic expectations and surgical suitability. Modern techniques emphasize minimal incision placement (inframammary, periareolar, or transaxillary), precise pocket dissection (subglandular, submuscular, or dual-plane), and textured or anatomical implants to optimize natural contour and reduce capsular contracture risk. Recovery typically spans 4–6 weeks, with long-term follow-up recommended for implant integrity monitoring.

China offers compelling advantages for international patients seeking breast augmentation: competitive pricing (30–50% lower than the U.S. or Western Europe), board-certified plastic surgeons trained in both Asian and Western aesthetic principles, state-of-the-art accredited hospitals (e.g., Jiahui Health, United Family, and top-tier public hospitals like Peking Union Medical College Hospital), and seamless medical tourism support—multilingual coordination, visa assistance, and postoperative telehealth follow-up. Chinese plastic surgery centers report >95% patient satisfaction rates and <2% major complication incidence in accredited facilities, with thousands of successful cases annually—including complex revisions and custom anatomical implant placements tailored to East Asian body proportions.

Treatment Options & Itemized Cost Breakdown: Breast Augmentation with Implants (Plastic Surgery Department)

Non-Surgical / Conservative Management

*No FDA- or NMPA-approved medications exist for breast volume enhancement.*

• •Observation & Counseling: For patients with mild asymmetry or unrealistic expectations; includes 2–3 sessions of psychological and aesthetic counseling.

- Tier 2 (Top-tier 3A, e.g., PUMCH, Ruijin): $75–$110 per session

• •Preoperative Optimization: Mandatory for all surgical candidates. Includes BMI management, smoking cessation support, and hormonal assessment (estradiol, prolactin).

- Breast ultrasound (bilateral): $22–$30 - Pre-anesthesia evaluation (EKG, chest X-ray if >45 yrs): $48–$65

Surgical / Procedural Options

*Eligibility*: Age ≥18, stable weight (BMI 18–32), no active infection, no uncontrolled autoimmune disease, no history of radiation to chest wall.

• •Saline Implants (Submuscular)

- Includes: Mentor or Sientra saline implants (US FDA/NMPA-cleared), endoscopic placement, drains, compression garment

• •Silicone Gel Implants (Submuscular or Dual-plane)

- Highly cohesive “gummy bear” (e.g., Natrelle 410, Sientra HSC): $6,200–$8,400 - *All include*: 2-night hospitalization, post-op imaging (MRI at 1 yr for silicone: $185)

• •Fat Grafting–Augmented Hybrid (Implant + Autologous Fat)

- Requires liposuction from ≥2 donor sites (abdomen/thighs) + processing + injection. - Cost range: $7,100–$9,300

Special/Complex Condition Options

• •Revision Surgery (Capsular Contracture Baker III/IV): Requires capsulectomy + implant exchange + acellular dermal matrix (Strattice or Belladerm).

• •Post-Mastectomy Reconstruction (Immediate/Delayed): NMPA-approved textured or smooth implants, often combined with tissue expander staging.

• •High-Risk Comorbidity Management (e.g., controlled diabetes, mild COPD): Requires extended pre-op workup + ICU-capable anesthesia team.

Quick Selection Guide

• •Age 18–25, Budget-Conscious, Minimal Volume Need: Saline implants ($3,200–$4,100) — lower upfront cost, adjustable fill volume.
• •Age 26–45, Prioritizing Natural Feel & Longevity: Standard silicone gel ($4,800–$6,900) — optimal balance of safety, aesthetics, and NMPA surveillance data.
• •Age >45 or History of Capsular Contracture: Highly cohesive silicone + intraoperative leukotriene inhibitor (montelukast) protocol ($6,200–$8,400) — reduced recurrence risk.
• •BMI >30 or Mild Comorbidities (HTN, T2DM): Hybrid approach with rigorous metabolic optimization + staged surgery ($7,100–$9,300) — lowers perioperative complication rates.
• •Post-Cancer Reconstruction: Two-stage tissue expander → implant ($9,400–$13,800) — gold standard for oncologic safety and symmetry control.